UBQLN3 Activators are a collection of chemicals that indirectly bolster the functional activity of UBQLN3 through multiple cellular signaling pathways and stress responses. Forskolin elevates cAMP, which activates PKA, potentially increasing phosphorylation events that modulate UBQLN3's activity in protein quality control. Ionomycin, by raising intracellular calcium levels, may influence UBQLN3's participation in calcium-dependent proteostasis. ALLN and MG132, by inhibiting calpain and the proteasome respectively, could lead to an accumulation of misfolded proteins, subsequently enhancing the role of UBQLN3 in protein triage decisions. Phorbol 12-myristate 13-acetate (PMA) activates PKC, possibly leading to phosphorylation of substrates that affect UBQLN3's function, while chloroquine and bafilomycin A1 disrupt lysosomal function, which may upregulate UBQLN3-mediated pathways as a compensatory mechanism.
Rapamycin and AICAR are known to induce autophagy; this might amplify UBQLN3's involvement in directing autophagic protein degradation. Retinoic acid could enhance UBQLN3 activity by modulating gene expression of proteins involved in UBQLN3-associated pathways. Tunicamycin and thapsigargin create ER stress by inhibiting glycosylation and disrupting calcium stores,respectively, potentially enhancing UBQLN3's response to misfolded proteins in the ER. The chemical influence of these activators demonstrates the multifaceted role of UBQLN3 in maintaining cellular proteostasis through various stress responses and regulatory mechanisms. Together, these compounds provide a diverse set of tools that can indirectly promote the functional activity of UBQLN3, ensuring the proper handling and turnover of proteins within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting calcium-dependent proteostasis mechanisms where UBQLN3 is involved. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, which could lead to an accumulation of misfolded proteins, potentially increasing the demand for UBQLN3's role in protein degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine inhibits lysosomal acidification, which may enhance UBQLN3's function by increasing the need for alternative degradation pathways that involve UBQLN3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can induce autophagy. UBQLN3 is suggested to be involved in autophagic degradation, and rapamycin could enhance this function of UBQLN3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can phosphorylate various substrates. Phosphorylation by PKC might influence UBQLN3's activity in protein degradation pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through nuclear receptors. It might enhance UBQLN3's function by influencing the transcription of genes involved in the pathways where UBQLN3 operates. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, causing ER stress. UBQLN3 could be activated in response to ER stress to facilitate the degradation of misfolded glycoproteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts ER calcium stores, causing ER stress. This might indirectly increase UBQLN3 activity as part of the cellular response to alleviate protein misfolding in the ER. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits the vacuolar-type H+-ATPase, disrupting autophagy and lysosomal acidification. This could lead to increased UBQLN3-mediated autophagic protein degradation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can induce autophagy. Activation of autophagy could enhance the role of UBQLN3 in directing proteins for autophagic degradation. | ||||||